A 32-year-old man with Bipolar Disorder I presents with a 3-week history of elevated mood, grandiosity, decreased need for sleep (3 hours/night), and pressured speech. He has been hospitalized twice before with similar presentations requiring antipsychotics. Regarding the pharmacological management of acute mania in Bipolar I disorder, all of the following are first-line agents EXCEPT:

Question

Accepted Answer

D. Selective serotonin reuptake inhibitors (SSRIs). ## Acute Mania Management in Bipolar I Disorder

### First-Line Pharmacological Options

**Key Point:** SSRIs are NOT first-line agents for acute mania in Bipolar I disorder; they may paradoxically worsen or precipitate manic episodes and are contraindicated as monotherapy.

| Agent Class | Role in Acute Mania | Evidence | Notes |
|---|---|---|---|
| Lithium | First-line | Gold standard, rapid onset | Narrow therapeutic window (0.6–1.2 mEq/L); requires monitoring |
| Valproate/Divalproex | First-line | Excellent efficacy | Faster onset than lithium; preferred in acute agitation |
| Atypical antipsychotics | First-line | Robust RCT data | Quetiapine, olanzapine, aripiprazole all FDA-approved |
| SSRIs | Contraindicated | Risk of mood destabilization | May trigger or worsen mania; only safe with mood stabilizer co-prescription |

### Why SSRIs Are Problematic in Bipolar I Mania

1. **Mood destabilization:** Monotherapy with SSRIs increases risk of manic/hypomanic switch.
2. **Lack of efficacy:** No evidence for benefit in acute mania; designed for depression.
3. **Clinical guideline consensus:** CANMAT, APA, and NICE guidelines explicitly recommend against SSRI monotherapy in Bipolar I disorder.

**High-Yield:** If an SSRI is deemed necessary (e.g., for comorbid depression in a bipolar patient), it MUST be co-prescribed with a mood stabilizer (lithium or anticonvulsant) or antipsychotic to prevent manic switch.

**Clinical Pearl:** In this case, the patient requires immediate mood stabilization with lithium, valproate, or an atypical antipsychotic—not an SSRI.

### Recommended Approach for This Patient

- **Acute phase:** Atypical antipsychotic (e.g., olanzapine 10–20 mg/day or quetiapine 300–600 mg/day) ± lithium or valproate.
- **Maintenance:** Lithium or valproate monotherapy or combination therapy to prevent relapse.

Answer

A. Valproate (divalproex sodium)

Answer

B. Lithium carbonate

Answer

C. Atypical antipsychotics (quetiapine, olanzapine, aripiprazole)

Explanation

Acute Mania Management in Bipolar I Disorder

First-Line Pharmacological Options

Why SSRIs Are Problematic in Bipolar I Mania

Recommended Approach for This Patient

Practice similar questions

Join our NEET PG community

Agent Class	Role in Acute Mania	Evidence	Notes
Lithium	First-line	Gold standard, rapid onset	Narrow therapeutic window (0.6–1.2 mEq/L); requires monitoring
Valproate/Divalproex	First-line	Excellent efficacy	Faster onset than lithium; preferred in acute agitation
Atypical antipsychotics	First-line	Robust RCT data	Quetiapine, olanzapine, aripiprazole all FDA-approved
SSRIs	Contraindicated	Risk of mood destabilization	May trigger or worsen mania; only safe with mood stabilizer co-prescription